FIXOPOST

This brand name is authorized in Estonia, Finland, Lithuania

Active ingredients

The drug FIXOPOST contains a combination of these active pharmaceutical ingredients (APIs):

1 Latanoprost
UNII 6Z5B6HVF6O - LATANOPROST

The active substance latanoprost, a prostaglandin F analogue, is a selective prostanoid FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humour. Reduction of the IOP in man starts about three to four hours after administration and maximum effect is reached after eight to twelve hours.

Read about Latanoprost
2 Timolol
UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01ED51 Timolol, combinations S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1730922, 1730933, 1787148, 1787159
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 455299, 599946
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085807, 1085808, 1092030, 1092031

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.